RecruitingPhase 4NCT06251076

Plan Development for Giving Teclistamab in the Outpatient Setting

Studying PLA2G6-associated neurodegeneration

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
University Health Network, Toronto
Principal Investigator
Christine Chen, Dr.
University Health Network, Toronto
Intervention
Teclistamab(drug)
Enrollment
15 enrolled
Eligibility
18 years · All sexes
Timeline
20242026

Study locations (1)

Collaborators

Janssen Inc.

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT06251076 on ClinicalTrials.gov

Other trials for PLA2G6-associated neurodegeneration

Additional recruiting or active studies for the same condition.

See all trials for PLA2G6-associated neurodegeneration

← Back to all trials